Hospira Gemcitabine Injection (38 mg/mL) 1 g/26.3 mL (US)

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

gemcitabine hydrochloride, Quantity: 43.27 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Gemcitabine hydrochloride

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 x 26.3 mL pack

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Ovarian cancer, breast cancer, non small cell lung cancer, pancreatic cancer

Resumen del producto:

Visual Identification: A clear, colourless or light straw coloured solution practically free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2011-11-04